American Renal Associates Holdings, Inc (ARA) Expected to Announce Earnings of $0.13 Per Share

Wall Street brokerages expect American Renal Associates Holdings, Inc (NYSE:ARA) to report $0.13 earnings per share (EPS) for the current fiscal quarter, Zacks Investment Research reports. Three analysts have issued estimates for American Renal Associates Holdings’ earnings. The lowest EPS estimate is $0.11 and the highest is $0.13. American Renal Associates Holdings posted earnings of $0.26 per share in the same quarter last year, which would indicate a negative year over year growth rate of 50%. The business is scheduled to announce its next quarterly earnings results on Tuesday, August 8th.

According to Zacks, analysts expect that American Renal Associates Holdings will report full-year earnings of $0.53 per share for the current year, with EPS estimates ranging from $0.50 to $0.57. For the next year, analysts anticipate that the business will report earnings of $0.69 per share, with EPS estimates ranging from $0.65 to $0.74. Zacks’ earnings per share averages are a mean average based on a survey of sell-side research analysts that cover American Renal Associates Holdings.

American Renal Associates Holdings (NYSE:ARA) last announced its quarterly earnings data on Tuesday, May 9th. The company reported $0.06 EPS for the quarter, missing the consensus estimate of $0.10 by $0.04. The company had revenue of $177 million during the quarter, compared to the consensus estimate of $184.67 million. American Renal Associates Holdings had a positive return on equity of 20.97% and a negative net margin of 2.13%. The business’s revenue was up 2.8% on a year-over-year basis. During the same period in the prior year, the firm posted $0.16 EPS.

Several equities analysts have issued reports on the stock. Wells Fargo & Company upgraded shares of American Renal Associates Holdings from a “market perform” rating to an “outperform” rating in a research note on Thursday, May 11th. Zacks Investment Research upgraded shares of American Renal Associates Holdings from a “sell” rating to a “hold” rating in a research note on Tuesday, May 16th. One research analyst has rated the stock with a sell rating, one has given a hold rating and five have assigned a buy rating to the stock. The company has an average rating of “Buy” and a consensus target price of $27.00.

Shares of American Renal Associates Holdings (ARA) traded up 1.61% during mid-day trading on Wednesday, reaching $17.67. 1,146,398 shares of the company’s stock traded hands. American Renal Associates Holdings has a 12-month low of $15.11 and a 12-month high of $28.53. The stock’s market cap is $550.44 million. The firm’s 50 day moving average price is $17.49 and its 200-day moving average price is $19.01.

Several institutional investors have recently modified their holdings of ARA. Atria Investments LLC acquired a new position in shares of American Renal Associates Holdings during the first quarter valued at $181,000. Oxford Asset Management acquired a new position in shares of American Renal Associates Holdings during the first quarter valued at $237,000. Lucus Advisors LLC acquired a new position in shares of American Renal Associates Holdings during the first quarter valued at $295,000. Martingale Asset Management L P acquired a new position in shares of American Renal Associates Holdings during the first quarter valued at $372,000. Finally, Teachers Advisors LLC boosted its position in shares of American Renal Associates Holdings by 42.6% in the fourth quarter. Teachers Advisors LLC now owns 20,092 shares of the company’s stock valued at $428,000 after buying an additional 6,000 shares during the period. Hedge funds and other institutional investors own 87.58% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: “American Renal Associates Holdings, Inc (ARA) Expected to Announce Earnings of $0.13 Per Share” was originally reported by WKRB News and is the property of of WKRB News. If you are reading this article on another website, it was copied illegally and republished in violation of U.S. and international copyright legislation. The original version of this article can be accessed at https://www.wkrb13.com/markets/2286509/american-renal-associates-holdings-inc-ara-expected-to-announce-earnings-of-0-13-per-share.html.

About American Renal Associates Holdings

American Renal Associates Holdings, Inc is a dialysis service provider in the United States focused on joint venture (JV) partnerships with physicians. As of December 31, 2016, the Company owned and operated 214 dialysis clinics in partnership with 379 nephrologist partners treating over 14,000 patients in 25 states and the District of Columbia.

Get a free copy of the Zacks research report on American Renal Associates Holdings (ARA)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for American Renal Associates Holdings (NYSE:ARA)

This story was originally published by WKRB News (https://www.wkrb13.com) and is the sole property of WKRB News. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at https://www.wkrb13.com/markets/2286509/american-renal-associates-holdings-inc-ara-expected-to-announce-earnings-of-0-13-per-share.html

Receive News & Ratings for American Renal Associates Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Renal Associates Holdings Inc and related companies with MarketBeat.com's FREE daily email newsletter.

 


Leave a Reply

 
© 2006-2017 WKRB News.